Insider filing · VOR

Ra Capital Management, L.P. sold $6.2M of Vor Biopharma (VOR)

Executed Oct 23 2025, disclosed Oct 27 2025, 4 days later.

Returns are measured on stock purchases only.

RP Ra Capital Management, L.P. Director profile →

Ra Capital Management, L.P. (Director) filed 31 Form 4 reports as a reporting entity in the trailing twelve months (23 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Artiva Biotherapeutics, Inc. (ARTV). Across 23 priced purchase filings, the average 21-session return was +14.9% from execution and +14.0% from disclosure (delay-adjusted; derived). The largest single filing was $423.8M of PBLS (21,188,750 sh across 2 lots, as filed), executed Jun 11.

VOR VOR VOR · 22 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→